US EditionAt Least 96 Dead After Receiving Contaminated Medical Fentanyl in Argentina
- The death toll from contaminated medical fentanyl in Argentina has risen to over 100, according to the government, which blamed HLB Pharma's lab for the crisis.
- Argentina has faced serious pharmaceutical scandals, with contaminated fentanyl leading to severe infections in patients, and authorities report ongoing investigations.
- Despite the recall of contaminated batches, new cases are still emerging, and no criminal charges have yet been filed against those involved in the production.
- The contaminated fentanyl has been linked to multidrug-resistant bacteria, affecting over 300,000 ampoules distributed to several provinces and Buenos Aires city.
16 Articles
16 Articles
The drug administered in several hospitals. Closed the laboratory that produces it
The deaths of a 87-year-old man and a 11-year-old girl were reported; both occurred in private clinics
At least 96 dead after receiving contaminated medical fentanyl in Argentina
Argentina’s drug regulator, Anmat, confirmed the presence of bacterial contamination both in samples taken from deceased patients and in ampoules from two specific fentanyl batches. One of these had been widely circulated.
Tainted fentanyl death toll surpasses 100 in Argentina
The death toll from contaminated fentanyl administered in Argentina’s hospitals grew to over 100 on Thursday, the government said, blaming a local pharma lab as outrage grew over the slow response to the crisis. Since May, the country has been trying to determine how many deaths were linked to bacteria-infected supplies of the drug used in hospitals in four provinces as well as the capital Buenos Aires. Ariel Furfaro Garcia, the owner of HLB Pha…
Ricardo Pieckenstainer explained the measures taken following the ANMAT alert. The number of victims of adulterated ampoules is 96 nationwide.
Coverage Details
Bias Distribution
- 75% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
